Emerald Growth Equity Strategy Sold Agilent (A) Due to Compression in the Margin of Safety

Emerald Wealth Partners, an independent asset and wealth management firm based in Zurich, released its Q4 2025 investor letter for the “Growth Equity Strategy.” A copy of the letter is available to download here. In 2025, the strategy returned +3.1% (gross) and +3.0% (net), resulting in the year-to-date return of 16.7% (gross) and +16.0% (net). Discussions on a potential bubble in Artificial Intelligence (AI) markets were a significant feature of 2025, especially in Q4, contributing to a pullback in AI stocks as investors expressed fears of an upcoming downturn. President Trump’s erratic trade and foreign policies were another challenge faced by the market in 2025. In addition, you can check the Strategy’s top 5 holdings to determine its best picks for 2025.

In its fourth-quarter 2025 investor letter, Emerald Growth Equity Strategy highlighted stocks like Agilent Technologies, Inc. (NYSE:A). Agilent Technologies, Inc. (NYSE:A) is a global leader in providing application-focused solutions for the life sciences, diagnostics, and applied chemical markets. On March 16, 2026, Agilent Technologies, Inc. (NYSE:A) stock closed at $111.83 per share. One-month return of Agilent Technologies, Inc. (NYSE:A) was -9.72%, and its shares lost 9.16% over the past 52 weeks. Agilent Technologies, Inc. (NYSE:A) has a market capitalization of $31.63 billion.

Emerald Growth Equity Strategy stated the following regarding Agilent Technologies, Inc. (NYSE:A) in its fourth quarter 2025 investor letter:

“In contrast, the outlook for Agilent Technologies, Inc. (NYSE:A) remains constructive. However, following a period of strong outperformance, the stock’s margin of safety compressed into the single-digit range, prompting us to take profits. Despite this reduction, we maintain a (reduced) overweight in the Life Science Sector for its improving growth outlook and attractive valuations.”

Agilent Technologies, Inc. (NYSE:A) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 71 hedge fund portfolios held Agilent Technologies, Inc. (NYSE:A) at the end of the fourth quarter, up from 53 in the previous quarter. While we acknowledge the potential of Agilent Technologies, Inc. (NYSE:A) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.